The Bapi Bust: Pfizer & J&J Shut Down Alzheimer’s Phase 3 Program
18:24 EDT 6 Aug 2012 | Forbes
Pfizer and Johnson & Johnson shut down their Alzheimer's drug program after a second trial failed to meet primary endpoints. One trial involved patients who do not carry the ApoE4, while the other did. Wall Street was not surprised and the bettin..
Original Article: The Bapi Bust: Pfizer & J&J Shut Down Alzheimer’s Phase 3 Program
More From BioPortfolio on "The Bapi Bust: Pfizer & J&J Shut Down Alzheimer’s Phase 3 Program"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
